Similar articles

• When informed consent is not required in studies.

  Maloney DM. Maloney DM. Hum Res Rep. 2006 Jun;21(6):3. Hum Res Rep. 2006. PMID: 17111532 No abstract available.
• FDA oversight of cell therapy clinical trials.

  Au P, Hursh DA, Lim A, Moos MC Jr, Oh SS, Schneider BS, Witten CM. Au P, et al. Sci Transl Med. 2012 Aug 29;4(149):149fs31. doi: 10.1126/scitranslmed.3004131. Sci Transl Med. 2012. PMID: 22932219
• Skin and bones: post-mortem markets in human tissue.

  Charo RA. Charo RA. Nova Law Rev. 2002 Winter;26(2):421-50. Nova Law Rev. 2002. PMID: 12627562 No abstract available.
• The impact of escalating regulatory requirements on the conduct of clinical research.

  Gordon BG, Kessinger A, Mann SL, Prentice ED. Gordon BG, et al. Cytotherapy. 2003;5(4):309-13. doi: 10.1080/14653240310002225. Cytotherapy. 2003. PMID: 12944237 Review.
• 31st Bethesda Conference. Emergency Cardiac Care. Task force 3: Special aspects of research conduct in the emergency setting: Waiver of informed consent.

  Passamani ER, Weisfeldt ML. Passamani ER, et al. J Am Coll Cardiol. 2000 Mar 15;35(4):862-80. J Am Coll Cardiol. 2000. PMID: 10732882 Review. No abstract available.